Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Centogene Announced Data Confirming The Utility Of Lyso-Gb1 (Glucosylsphingosine) As A Sensitive Biomarker For Gaucher Disease, The Findings From The Study Also Indicate Lyso-Gb1 Could Help To Predict Clinical Course, Improve Personalized Care

Author: Benzinga Newsdesk | September 01, 2023 08:03am

Posted In: CNTG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist